home.social

#newenglandjournalofmedicine — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #newenglandjournalofmedicine, aggregated by home.social.

  1. Amgen, AstraZeneca Combo Cuts Death Risk 58% in Small Cell Lung Cancer, Extends Survival by 8.4 Months — BigGo Finance

    In a Phase 3 trial, combining Amgen’s lung cancer drug Imdelltra (generic name tarlatamab) with AstraZeneca’s immuno-oncology drug…
    #EuropeSays #Britain #Europe #EU #AstraZeneca #Amgen #DeLLphi-305 #durvalumab #EuropeanSocietyforMedicalOncology #Imdelltra #Imfinzi #NewEnglandJournalofMedicine #smallcelllungcancer #tarlatamab
    europesays.com/britain/151102/

Share on Mastodon

Enter the server where you have an account.